Vaccine News and Research

Latest Vaccine News and Research

Ensuring 100% Accuracy in Antibody Protein Sequencing

The purpose of antibody protein sequencing is to accurately deduce every single amino acid present in the primary sequence. This is an issue with isoleucine and leucine which have the same molecular weight. Rapid Novor has developed a technique to determine these with 100% accuracy.

From Rapid Novor Inc 16 Apr 2019

Researchers discover how liver cells protect against viral attacks

Liver cells have an innate resistance to RNA viral infections like hepatitis A, dengue and Zika thanks to a protein called IRF1, according to researchers at the University of North Carolina at Chapel Hill and Tokyo Metropolitan Institute of Medical Science.

16 Apr 2019

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

15 Apr 2019

Measles epidemic kills over 1,200 in Madagascar

There have been a reported over 115,000 cases and over 1,200 deaths due to measles in Madagascar according to reports. This is one of the largest epidemics of a vaccine preventable viral disease in the recent times, say experts.

15 Apr 2019

Research highlights the importance of seeking prompt medical advice following rabies exposure

There is only a short window of opportunity to seek medical help before rabies becomes almost invariably fatal, but people wait an average of 10 days before seeking medical advice following exposure to potentially rabid animals overseas, according to new research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, Netherlands (13-16 April).

15 Apr 2019

Study: Despite substantial progress, many African countries have wide discrepancies in vaccine coverage

Many African nations have made substantial progress in vaccinating children against life-threatening diseases, however, within countries wide discrepancies remain, according to a new scientific study.

12 Apr 2019

Several low-and middle-income countries need more effective child vaccination strategies

A study by the University of Southampton shows that several low-and middle-income countries, especially in Africa, need more effective child vaccination strategies to eliminate the threat from vaccine-preventable diseases.

11 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

Researchers develop potent and safe vaccine against deadly MERS

A collaborative team from The University of Texas Medical Branch at Galveston, Saudi Arabia and Canada developed a potent and safe vaccine that protects against the deadly Middle East respiratory syndrome, or MERS. The findings recently were published in The Journal of Infectious Diseases.

10 Apr 2019

Key gene involved in transmission of African sleeping sickness identified

Life scientists from UCLA and the University of Bern have identified a key gene in the transmission of African sleeping sickness -- a severe disease transmitted by the bite of infected tsetse flies, which are common in sub-Saharan Africa.

10 Apr 2019

HPV vaccination rates are low, especially in HIV prone populations

HPV vaccination rates in populations at high-risk of contracting HIV are particularly low, increasing the risk of HPV and HIV co-infection.

10 Apr 2019

Common food preservative could make flu vaccine less effective

A preservative commonly used to increase the shelf life of food products may weaken the body’s immune defense against influenza, thus reducing the response to the flu vaccine.

9 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

Experts detail efforts to improve seasonal and universal influenza vaccine

In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza vaccine.

9 Apr 2019

Cancer vaccine injected into tumour could kill all cancer cells

Researchers have developed an experimental cancer vaccine that when injected into a single tumour can help trigger the immune system to kill the cancer cells circulating within the body. The results of the study titled, “Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination,” were published in the latest issue of the journal Nature Medicine, this week, Monday.

9 Apr 2019

Boys having sex too early, finds study

A significant percentage of boys are having sex too early finds a new study. Several factors have been cited as possible associated cause of such occurrences. The results of the study titled, “Prevalence of Sexual Initiation Before Age 13 Years Among Male Adolescents and Young Adults in the United States,” were published in the latest issue of the journal JAMA Pediatrics this week.

8 Apr 2019

Cellular protein could take on role of restriction factor for hepatitis B virus

Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not curative for infected individuals.

8 Apr 2019

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

A DNA-encoded monoclonal antibody prevents Zika infection in mice and non-human primates, researchers report April 5 in the journal Molecular Therapy.

8 Apr 2019

Novel models and strategies for TB detection, elimination, and care

This week, publication of a special issue on tuberculosis begins in PLOS Medicine, advised by guest editors Richard Chaisson of Johns Hopkins University, Claudia Denkinger of the University of Heidelberg, and Mark Hatherill of the South African Tuberculosis Vaccine Institute.

8 Apr 2019